Plant-derived medicines are prone to shortages because their agriculture-based supply chains are vulnerable to geopolitical and environmental factors. Recreating the biosynthesis of these medicines in a scalable organism like Baker’s yeast would provide an economical alternative to plant cultivation that is resilient to regional and global disruptions and scalable to meet global demands.
Download this app note to discover how gene fragments can:- Reduce the time it takes to screen clones
- Remove a critical bottleneck in the engineering workflow
